Fig. 2From: Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trialsThe assessment of the quality of clinical trials is shown. a Risk of bias graph. b Risk of bias summary. (+) denotes a low risk of bias; (−) denotes a high risk of bias; (?) denotes an unclear risk of biasBack to article page